Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PTLA | Portola Pharmaceuticals, Inc. | -0.31% | 17.90 | 6.5% | $164.61m | |
| HZNP | Horizon Therapeutics Plc | -1.81% | 49.81 | 6.5% | $143.70m | |
| CTLT | Catalent, Inc. | -0.52% | 77.33 | 2.3% | $138.32m | |
| MYOK | MyoKardia, Inc. | 2.30% | 104.65 | 1.8% | $133.36m | |
| BHC | Bausch Health Cos., Inc. | 5.47% | 19.49 | 0.0% | $126.05m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 5.36% | 19.47 | 14.1% | $114.56m | |
| UTHR | United Therapeutics Corp. | 1.47% | 119.68 | 14.3% | $76.28m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 2.01% | 73.71 | 16.8% | $60.87m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.04% | 119.37 | 2.4% | $60.67m | |
| GWPH | GW Pharmaceuticals Plc | 2.50% | 125.82 | 6.2% | $57.38m | |
| AMRN | Amarin Corp. Plc | -2.19% | 6.71 | 1.6% | $56.72m | |
| ARGX | argenx SE | 1.70% | 223.02 | 0.0% | $53.79m | |
| AXSM | Axsome Therapeutics, Inc. | -0.97% | 76.23 | 1.9% | $50.18m | |
| PRGO | Perrigo Co. Plc | 1.88% | 55.80 | 6.8% | $46.61m | |
| ICLR | ICON plc | 1.32% | 170.68 | 4.3% | $45.03m |
Company Profile
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.